This inventor holds 57 USPTO granted patents, primarily in Heterocyclic Compounds (CPC class 5143). Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft. Active years: 1993-2005.
Inventors with similar research interests:
Company Filing History:
55 out of 12,266Â 
2 out of 386Â 
Years Active: 1993-2005
Areas of Expertise:
Title: Stefan Wohlfeil: Pioneering Innovations in Medicaments
Introduction:
Stefan Wohlfeil, a visionary inventor based in Hilden, Germany, has etched his name in the annals of innovation with his remarkable contributions to the field of medicaments. With a prolific track record of 57 patents, Wohlfeil's passion for innovation and relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.
Latest Patents:
Wohlfeil's latest patents revolve around Cycloalkano-indole and -azaindole derivatives. These compounds are synthesized by the reaction of appropriately substituted carboxylic acids with amines, showcasing his expertise in medicinal chemistry. The Cycloalkano-indole and -azaindole derivatives have shown promise as active compounds for medicaments, particularly in the realm of antiatherosclerotic treatments.
Career Highlights:
Wohlfeil's illustrious career includes pivotal roles at Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft, where he played a significant part in driving innovation and spearheading groundbreaking research in pharmaceuticals. His in-depth knowledge and innovative approach have been instrumental in the development of novel medical solutions aimed at improving patient outcomes.
Collaborations:
Throughout his career, Wohlfeil has collaborated with esteemed professionals in the industry, including Martin Beuck and Ulrich E. Muller. These partnerships have been instrumental in fostering a culture of collaboration and knowledge-sharing, leading to the successful realization of innovative projects and patents.
Conclusion:
In conclusion, Stefan Wohlfeil's unwavering dedication to innovation and his remarkable contributions to the field of medicaments have not only positioned him as a trailblazing inventor but also as a guiding light for aspiring inventors worldwide. His legacy serves as a testament to the transformative power of innovation in shaping the future of healthcare and technology.